Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines

EuroIntervention

Volumn 7, Issue 1, 2011, Pages 41-48

  Gurvitch, Ronen ^a   Toggweiler, Stefan ^a   Willson, Alexander B ^a   Wijesinghe, Namal ^a   Cheung, Anson ^a   Wood, David A ^a   Ye, Jian ^a   Webb, John G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Aortic stenosis; Complications; Transcatheter aortic valve implantation

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; ANATOMICAL VARIATION; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DEVICE SAFETY; EQUIPMENT DESIGN; ERYTHROCYTE TRANSFUSION; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PROSTHESIS FAILURE; SCORING SYSTEM; SURGICAL MORTALITY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT RESPONSE; AORTA VALVE; BALLOON DILATATION; BLOOD TRANSFUSION; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; INSTRUMENTATION; METHODOLOGY; MORTALITY; POSTOPERATIVE COMPLICATION; STROKE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE; BALLOON DILATION; BLOOD TRANSFUSION; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; STROKE; TREATMENT OUTCOME;

EID: 80051751721     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I1A10     Document Type: Article

References (36)

1. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv. 2008;1:167-175.
2. Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation. 2009;119:3009-3016.
3. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochelliere R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol.2010;55:1080-1090.
4. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32:205-217.
5. Gurvitch R, Tay E, Wijesinghe N, Ye J, Nietlispach F, Wood DA, Lichtenstein SV, Cheung A, Webb JG. Transcatheter Aortic Valve Implantation: Lessons from the Learning Curve of the First 270 High Risk Patients. Catheterization Cardiovasc Interv.2011;In Press.
6. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S, Lichtenstein S. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113:842-850.
7. Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, Webb JG. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation. 2006;114:591-596. (Pubitemid 44202060)
8. Webb JG, Pasupati S, Achtem L, Thompson CR. Rapid pacing to facilitate transcatheter prosthetic heart valve implantation. Catheter Cardiovasc Interv. 2006;68:199-204. (Pubitemid 44167668)
9. Webb JG, Altwegg L, Masson JB, Al Bugami S, Al Ali A, Boone RA. A new transcatheter aortic valve and percutaneous valve delivery system. J Am Coll Cardiol. 2009;53:1855-1858.
10. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62-69.
11. Tamburino C, Capodanno D, Mule M, Scarabelli M, Cammalleri V, Barbanti M, Calafiore A, Ussia G. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol. 2009;21:93-98.
12. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242-249.
13. Osten MD, Feindel C, Greutmann M, Chamberlain K, Meineri M, Rubin B, Mezody M, Ivanov J, Butany J, Horlick EM. Transcatheter aortic valve implantation for high risk patients With severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: A single centre study with immediate and medium-term outcomes. Catheter Cardiovasc Interv. 2009
14. Okamura H, Yamaguchi A, Noguchi K, Naito K, Yuri K, Adachi H. Hemodynamics and outcomes of aortic valve replacement with a 17- or 19-mm valve. Asian Cardiovasc Thorac Ann. 2010;18:450-455.
15. Botzenhardt F, Eichinger WB, Bleiziffer S, Guenzinger R, Wagner IM, Bauernschmitt R, Lange R. Hemodynamic comparison of bioprostheses for complete supra-annular position in patients with small aortic annulus. J Am Coll Cardiol. 2005;45:2054-2060. (Pubitemid 40814131)
16. Bortolotti U, Scioti G, Milano A, De Carlo M, Codecasa R, Nardi C, Tartarini G. Performance of 21-mm size perimount aortic bioprosthesis in the elderly. Ann Thorac Surg. 2000;69:47-50. (Pubitemid 30078819)
17. Jamieson WR, Janusz MT, MacNab J, Henderson C. Hemodynamic comparison of second- and third-generation stented bioprostheses in aortic valve replacement. Ann Thorac Surg. 2001;71:S282-4. (Pubitemid 32436980)
18. Minardi G, Pino PG, Manzara CC, Pulignano G, Viceconte GN, Stefanini GG, Gaudio C, Musumeci F. Early Doppler-echocardiography evaluation of 597 prosthetic aortic valves. J Cardiovasc Med (Hagerstown). 2010;11:229-233.
19. Goetzenich A, Langebartels G, Christiansen S, Hatam N, Autschbach R, Dohmen G. Comparison of the Carpentier-Edwards Perimount and St. Jude Medical Epic bioprostheses for aortic valve replacement - a retrospective echocardiographic short-term study. J Card Surg. 2009;24:260-264.
20. Gurvitch R, Wood DA, Tay EL, Leipsic J, Ye J, Lichtenstein SV, Thompson CR, Carere RG, Wijesinghe N, Nietlispach F, Boone RH, Lauck S, Cheung A, Webb JG. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation. 2010;122:1319-1327.
21. Clavel MA, Webb JG, Pibarot P, Altwegg L, Dumont E, Thompson C, De Larochelliere R, Doyle D, Masson JB, Bergeron S, Bertrand OF, Rodes-Cabau J. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol. 2009;53:1883-1891.
22. Jilaihawi H, Webb JG, Gurvitch R, Ye J, Cheung A, Chin D, Spyt T, Kovac J. Determinants and Outcomes of Valvular Dysfunction Following Transcatheter Aortic Valve Implantation. Circulation. 2010;122:A21129 (AHA 2011 - Abstract).
23. Clavel MA, Rodes-Cabau J, Dumont E, Bergeron S, Bagur R, De Larochelliere R, Doyle D, Larose E, Pibarot P. Method to Measure the Valve Effective Orifice Area Following Transcatheter Aortic Valve Implantation. Circulation. 2010;122:A10394 (AHA 2011 - Abstract).
24. Ducrocq G, Francis F, Serfaty JM, Himbert D, Maury JM, Pasi N, Marouene S, Provenchere S, Iung B, Castier Y, Leseche G, Vahanian A. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention. 2010;5:666-672.
25. Van Mieghem NM, Nuis RJ, Piazza N, Apostolos T, Ligthart J, Schultz C, de Jaegere PP, Serruys PW. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention.2010;5:673-679.
26. Kahlert P, Al-Rashid F, Weber M, Wendt D, Heine T, Kottenberg E, Thielmann M, Kuhl H, Peters J, Jakob HG, Sack S, Erbel R, Eggebrecht H. Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz. 2009;34:398-408.
27. Tchetche D, Dumonteil N, Sauguet A, Descoutures F, Luz A, Garcia O, Soula P, Gabiache Y, Fournial G, Marcheix B, Carrie D, Fajadet J. Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population. EuroIntervention. 2010;5:659-665.
28. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
29. Ferraris VA, Ferraris SP, Saha SP, Hessel EAn, Haan CK, Royston BD, Bridges CR, Higgins RS, Despotis G, Brown JR, Spiess BD, Shore-Lesserson L, Stafford-Smith M, Mazer CD, Bennett-Guerrero E, Hill SE, Body S. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007;83:S27-86.
30. Likosky DS, FitzGerald DC, Groom RC, Jones DK, Baker RA, Shann KG, Mazer CD, Spiess BD, Body SC. The effect of the perioperative blood transfusion and blood conservation in cardiac surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practices. J Extra Corpor Technol. 2010;42:114-121.
31. Himbert D, Descoutures F, Al-Attar N, Iung B, Ducrocq G, Detaint D, Brochet E, Messika-Zeitoun D, Francis F, Ibrahim H, Nataf P, Vahanian A. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol. 2009;54:303-311.
32. E. Tay RG, N. Wijesinghe, F. Nietlispach, D. Wood, J. Ye, A. Cheung, R. Carere, S. Lichtenstein, C. Thompson, J. Webb. Cerebrovascular Events Following Transcatheter Aortic Valve Replacement-Incidence, Predictors and Timing of Events. Heart, Lung and Circulation. 2010;19Supplement 2:S123.
33. Ghanem A, Muller A, Nahle CP, Kocurek J, Werner N, Hammerstingl C, Schild HH, Schwab JO, Mellert F, Fimmers R, Nickenig G, Thomas D. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010;55:1427-1432.
34. Rodes-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bedard F, Doyle D, De Larochelliere R, Jayasuria C, Villeneuve J, Marrero A, Cote M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2010;57:18-28.
35. Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochelliere R, Doyle D, Masson JB, Gutierrez MJ, Clavel MA, Bertrand OF, Pibarot P, Rodes-Cabau J. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31:865-874.
36. Aregger F, Wenaweser P, Hellige GJ, Kadner A, Carrel T, Windecker S, Frey FJ. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant. 2009;24:2175-2179.